NCT04336683

Brief Summary

Brachytherapy treatment in gynecological cancers is an essential component to delivering adequate doses of radiation to a tumour while sparing normal tissue. Interstitial and intracavitary brachytherapy is often needed in advanced or recurrent disease, in cases where intrauterine brachytherapy may not deliver the optimal outcome. Interstitial brachytherapy is based on a defined template-and-needle system, and the procedure relies on clinical examination and pre-treatment imaging to guide needle insertion. There is currently no standard image-guided process to help direct needles in the pelvis. The investigators propose a 3D ultrasound device that will provide real-time imaging for the brachytherapy procedure which will aid in avoiding needle insertion into pelvic organs and result in optimal dose coverage to the tumour.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
35

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 17, 2015

Completed
5.1 years until next milestone

First Submitted

Initial submission to the registry

March 10, 2020

Completed
28 days until next milestone

First Posted

Study publicly available on registry

April 7, 2020

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2021

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 7, 2022

Completed
Last Updated

May 17, 2023

Status Verified

May 1, 2023

Enrollment Period

6.3 years

First QC Date

March 10, 2020

Last Update Submit

May 15, 2023

Conditions

Keywords

3D UltrasoundIntervention

Outcome Measures

Primary Outcomes (1)

  • Efficacy of the 3DUS device to visualize applicators

    The number of applicators identified within the 3D ultrasound image.

    16 Weeks

Secondary Outcomes (1)

  • 3DUS to CT Fusion

    16 Weeks

Study Arms (1)

Patient

OTHER

Patients undergoing gynecological brachytherapy, will be imaged with a 3D ultrasound medical device for the purpose of efficacy testing.

Device: Interstitial and intracavitary brachytherapy

Interventions

Standard of care in interstitial or intracavitary brachytherapy is to insert the brachytherapy needle and applicator with no standard real-time image guidance. Interstitial brachytherapy is done under general anesthesia. Trans-abdominal and trans-rectal standard 2D ultrasound is used in some cases, but is typically not consistent and therefore its value is limited. Pre-procedure imaging in the form of MRI is used to help guide needles insertion as well as the clinical exam. Post-procedure CT is done for radiation planning

Patient

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsFemales patients with locally advanced or recurrent gynecological malignancies who are offered interstitial or intracavitary brachytherapy treatment.
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with locally advanced or recurrent gynecological malignancies who are offered interstitial or intracavitary brachytherapy treatment. These typically would include patients with primary or recurrent vaginal cancers, endometrial cancers or cervical cancers. Histologies of these cancers are typically adenocarcinomas or squamous cell carcinomas

You may not qualify if:

  • Above patients who are not offered interstitial or intracavitary brachytherapy as a treatment modality

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

London Regional Cancer Program, Victoria Hospital

London, Ontario, N6A 5W9, Canada

Location

Related Publications (3)

  • Rodgers JR, Hrinivich WT, Surry K, Velker V, D'Souza D, Fenster A. A semiautomatic segmentation method for interstitial needles in intraoperative 3D transvaginal ultrasound images for high-dose-rate gynecologic brachytherapy of vaginal tumors. Brachytherapy. 2020 Sep-Oct;19(5):659-668. doi: 10.1016/j.brachy.2020.05.006. Epub 2020 Jul 3.

  • Rodgers JR, Bax J, Surry K, Velker V, Leung E, D'Souza D, Fenster A. Intraoperative 360-deg three-dimensional transvaginal ultrasound during needle insertions for high-dose-rate transperineal interstitial gynecologic brachytherapy of vaginal tumors. J Med Imaging (Bellingham). 2019 Apr;6(2):025001. doi: 10.1117/1.JMI.6.2.025001. Epub 2019 Apr 8.

  • Rodgers JR, Mendez LC, Hoover DA, Bax J, D'Souza D, Fenster A. Feasibility of fusing three-dimensional transabdominal and transrectal ultrasound images for comprehensive intraoperative visualization of gynecologic brachytherapy applicators. Med Phys. 2021 Oct;48(10):5611-5623. doi: 10.1002/mp.15175. Epub 2021 Sep 2.

MeSH Terms

Interventions

Brachytherapy

Intervention Hierarchy (Ancestors)

RadiotherapyTherapeutics

Study Officials

  • David D'Souza, MD

    Schulich School of Medicine and Dentistry

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: Patients who are assigned to gynecological brachytherapy.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 10, 2020

First Posted

April 7, 2020

Study Start

February 17, 2015

Primary Completion

June 15, 2021

Study Completion

April 7, 2022

Last Updated

May 17, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will not share

Locations